SCHEMBL26027490

SCHEMBL26027490

CCc1cc(S(=O)(=O)c2ccccc2)cc(N2CCOCC2)n1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 13/20 0.58
MTOR P42345 3/20 0.58
AKT1 P31749 2/20 0.58
PIK3C3 Q8NEB9 3/20 0.57
PKM P14618 1/20 0.53
TSHR P16473 1/20 0.53
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
KMT2A Q03164 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.50
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
PIK3CB P42338 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21464528 0.81 PIK3CA (0.61) PIK3CAMTORAKT1PIK3C3PKM
SCHEMBL30826822 0.81 PIK3CA (0.61) PIK3CAMTORAKT1PIK3C3PKM
SCHEMBL7137232 0.78 HTR6 (0.67) PIK3CAMTORAKT1PIK3C3PKM
SCHEMBL26027776 0.76 PIK3CA (0.65) PIK3CAMTORAKT1PIK3C3ALDH1A1
SCHEMBL26027646 0.76 PIK3CA (0.58) PIK3CAMTORAKT1PKMTSHR
SCHEMBL4791302 0.75 MTOR (0.64) PIK3CAMTORAKT1PKMALDH1A1
SCHEMBL10272785 0.74 KMT2A (0.75) PIK3CAMTORTSHRALDH1A1MEN1
SCHEMBL29923007 0.74 PIK3CA (1.00) PIK3CAMTORAKT1PIK3C3
SCHEMBL21464219 0.74 PIK3CA (1.00) PIK3CAMTORAKT1PIK3C3
SCHEMBL12110343 0.73 KMT2A (0.51) AKT1PKMTSHRALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265086-A1 TRI-SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF PI3-KINASE AND AUTOPHAGY PATHWAYS NEUROPORE THERAPIES, INC. (US) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265086-A1 TRI-SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF PI3-KINASE AND AUTOPHAGY PATHWAYS ATG7, ULK1, BECN1 PIK3CA 31/4885MTOR 4/4885AKT1 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.